Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women
Pilar Requena(Instituto de Investigación Biosanitaria de Granada), Carlota Dobaño(Manhiça Health Research Centre), Azucena Bardají(Kenya Medical Research Institute), Norma Padilla(Universidad del Valle de Guatemala), Regina Wangnapi(Papua New Guinea Institute of Medical Research), Myriam Arévalo‐Herrera(Caucaseco Scientific Research Center), Clara Menéndez(Barcelona Institute for Global Health), Edmilson Rui(Barcelona Institute for Global Health), Michela Menegon(Istituto Superiore di Sanità), Camila Bôtto-Menezes(Fundação de Medicina Tropical), Ivo Müeller(The University of Melbourne), Stephen J. Rogerson(The University of Melbourne), Flor Ernestina Martínez-Espinosa(Fundação de Medicina Tropical), Meghna Desai(Centers for Disease Control and Prevention), Alfredo Mayor(Barcelona Institute for Global Health), Hernando A. del Portillo(Institució Catalana de Recerca i Estudis Avançats), Francesca Mateo(Institut d'Investigació Biomédica de Bellvitge), Maria Ome‐Kaius(The University of Melbourne), María Eugenia Castellanos(Universidad del Valle de Guatemala), Dhiraj Hans(International Centre for Genetic Engineering and Biotechnology), Sergi Sanz(Barcelona Institute for Global Health), Adriana Malheiro, Swati Kochar(Sardar Patel Medical College), Alexandra J. Umbers(The University of Melbourne), Sanjay Kumar Kochar(Sardar Patel Medical College), Carlo Severini(Istituto Superiore di Sanità), Dhanpat Kumar Kochar(Sardar Patel Medical College), Carmen Fernández-Becerra(Barcelona Institute for Global Health)
Cited by 25
Related Papers
Database resources of the National Center for Biotechnology Information
|Nucleic Acids Research|2017|1.6k
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
|Journal of Clinical Investigation|2012|462
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
|Stem Cells Translational Medicine|2017|359